
Yvette Beattie joins Toomac
Toomac Ophthalmic has appointed Yvette Beattie as its new pharmaceutical account manager.

Toomac Ophthalmic has appointed Yvette Beattie as its new pharmaceutical account manager.

Researchers in India have found that ocular findings and leukaemia subtype can predict visual prognosis, with AML and CML linked to poorer outcomes. In a retrospective review of 244 patients (378

Researchers in China have validated a self-administered version of the ETDRS visual acuity (VA) chart to monitor patients with retinal disease. Published in the British Journal of Ophthalmology,

A study by researchers in Argentina showed daily eye drops combining pilocarpine and diclofenac significantly improved near vision in people with presbyopia, with benefits sustained for up to two year

LINK: https://www.nzoptics.co.nz/live-articles/valacyclovir-shows-promise-against-hzo/

Central serous chorioretinopathy (CSCR), characterised by serous detachment of the neurosensory retina and detachments of an altered retinal pigment epithelium (RPE), can be frustrating for both patie

VirtuaLens announced the launch of the Immersive IOL Simulator, described as a virtual reality (VR) platform to help cataract patients explore and compare intraocular lens (IOL) options before surgery

LINK: https://www.nzoptics.co.nz/live-articles/new-board-members-appointed/

An Israeli study found topical beta-blockers used to treat glaucoma were not associated with an increased risk of Parkinson’s disease (PD). Writing in the British Journal of Ophthalmology, autho

Ashvattha Therapeutics reported the results of a phase 2 trial of migaldendranib (MGB), its monthly ‘at-home’ subcutaneous anti-VEGF injection, showed it reduced treatment burden and improved visual a

LINKS: https://nzoptics.co.nz/live-articles/save-sight-symposium-2024-ideas-and-innovations-in-eye-health/

LINK: https://nzoptics.co.nz/live-articles/alcon-unveils-unity/